Outsourced Pharma App Notes & Case Studies

  1. Paediatric Drug Product Development Through To Commercialisation 9/3/2026

    Learn how an innovative pediatric minitablet achieved patient-friendly administration, precise dosing and scalable manufacturing to support a smooth path to market.

  2. Generation Of A Contamination Control Strategy 8/16/2025

    An unaddressed compliance issue related to contamination control can pose a significant risk to a life sciences organization. This case study details a company's journey toward sustainable compliance.

  3. Diversifying Single-Use Technology With Cytiva XDR Bioreactors 3/25/2025

    Explore how our flexible single-use bioreactor systems, including the Cytiva Xcellerex Disposable Reactors, can efficiently scale your production while maintaining process consistency and product quality.

  4. Formulation & Delivery Of Spray Dried Biologics For Nasal Dosage Forms 4/27/2026

    Spray drying enables stable, scalable dry‑powder nasal biologics, improving shelf life, particle control, and targeted delivery for peptides, proteins, vaccines, and oligonucleotides.

  5. mRNA Manufacturing With Fed-Batch In Vitro Transcription 2/13/2026

    A milliliter-scale approach to IVT optimization reveals how controlled feeding, precise pH management, and real-time monitoring can boost mRNA yield and streamline scale-up to larger bioreactor volumes.

  6. High Drug Tolerance ADA Testing For Long‑Acting mAbs 5/6/2026

    See how advanced ADA assay design overcomes extreme drug interference, enabling reliable immunogenicity assessment for long‑acting, high‑dose monoclonal antibodies in early clinical development.

  7. Patient Adherence With A Novel Dosage Form 11/13/2025

    A sprinkle formulation helps patients with tremors or dysphagia take medication more easily, improving adherence, comfort, and care through a novel, FDA-approved oral granule format.

  8. Development Of A Non-Standard Protein Therapeutic 2/4/2026

    Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.

  9. From Variability To Validation – GMP Bioassay Success Through Partnership 2/27/2026

    Turn your inconsistent bioassays into GMP-validated, high-reliability platforms — just like we helped a biopharma partner cut failure rates from ~25% to <1%.

  10. Application Of A Dual Spiking Strategy In Viral Clearance Studies 2/3/2026

    Explore how an alternative spiking strategy can streamline viral clearance studies, reduce material demands, and maintain compliance while addressing the challenges posed by MLV and MMV.